iodine-125


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.iodine-125 - light radioactive isotope of iodine with a half-life of 60 days; used as a tracer in thyroid studies and as a treatment for hyperthyroidism
radioisotope - a radioactive isotope of an element; produced either naturally or artificially
atomic number 53, I, iodin, iodine - a nonmetallic element belonging to the halogens; used especially in medicine and photography and in dyes; occurs naturally only in combination in small quantities (as in sea water or rocks)
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
It reported long-term follow-up data collected on Cesium-131 as compared to Iodine-125, a long-established prostate brachytherapy isotope.
There has been increasing use of radioisotopes to label nanoparticles, such as positron emitters copper-64 [26], gallium-67 [27], and zirconium-89 [28], and single photon emitters Technetiom-99m [3] and radioiodine (e.g., iodine-125 [29], iodine-123, and iodine-131 [30]).
The first of these uses an iodine-125 radioactive seed, which allows placement up to 5 days before surgery.
Background: Portal-vein stent combined with one iodine-125 ([sup]125I) seed strand has become a new treatment for portal vein tumor thrombosis.
Patients with advanced disease (stages III and IV) received either cranial-spinal radiotherapy (external beam radiotherapy) after six cycles of chemotherapy had been completed or iodine-125 brachytherapy in Cape Town.
Significant isotopes in the brachytherapy market are cesium-131(Cs-131), iodine-125 (I-125), palladium-103 (Pd-103), and iridium-192 (Ir-192).
PMH has reported outcomes on 776 men (median age: 63) treated with iodine-125 PB for low- (85%) or intermediate-risk prostate (5%) cancer with minimum 3-year PSA follow-up.
For 5 weeks, mice were irradiated continuously with 35.5 keV X-rays produced by the decay of iodine-125, yielding an accumulated dose of 105 mGy.
A 50-year-old male patient with a history of prostate cancer treated with iodine-125 seed implants and previously documented degenerative lumbar spinal stenosis with chronic low back pain presented to the emergency room with severe low back and right flank pain.
The one-year agreement, effective May 1, 2011, covers the marketing of Oncura's complete line of Iodine-125 brachytherapy products.